A new study conducted by the Department of Diagnostic and Biological Sciences at the University of Minnesota, and published in the most recent issue of the journal Neuroscience, has found that cannabinoids – compounds found in cannabis such as THC – can stop the pain associated with bone cancer by activating an individual’s cannabinoid receptors.
“These results indicate that activation of either CB1 or CB2 receptors reduced the spontaneous activity of C-fiber nociceptors associated with tumor growth as well as their evoked responses”, states the study’s abstract, “Our results provide further evidence that activation of peripheral cannabinoid receptors may be a useful target for the treatment of cancer pain.”
The potential of cannabis as a treatment for cancer pains is an important one. As researchers note; “Pain from cancer can be severe, difficult to treat, and greatly diminishes patients’ quality of life. It is therefore important to gain new information on the mechanisms of cancer pain and develop new treatment strategies.”
Obviously further research is needed to help validate these findings, but they’re certainly promising.